Clinical case analysis of 2019 coronavirus disease (COVID-19) with living-related kidney transplantation
10.3760/cma.j.cn421203-20200226-00049
- VernacularTitle:亲属活体肾移植受者新型冠状病毒肺炎一例报告及临床特征分析
- Author:
Xia LU
1
;
Changsheng MING
;
Zhixiang WEN
;
Liru QIU
;
Shuyun XU
;
Tao CHEN
;
Qin NING
;
Xiaoping LUO
;
Zhishui CHEN
;
Nianqiao GONG
Author Information
1. 华中科技大学同济医学院附属同济医院器官移植研究所 教育部器官移植重点实验室 国家卫生健康委员会器官移植重点实验室 中国医学科学院器官移植重点实验室，武汉 430030
- From:
Chinese Journal of Organ Transplantation
2020;41(3):148-151
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the clinical characteristics of one living-related kidney transplant recipient infected with 2019 coronavirus disease(COVID-19).Methods:The clinical diagnosis and treatment of one living-related kidney transplant recipient after the occurrence of COVID-19 were analyzed retrospectively. Course of onset, clinical manifestations, laboratory and image enamination, outpatient and inpatient therapies and outcomes.Results:The renal transplant recipient was diagnosed as COVID-19(severe) with influenza A virus infection based upon epidemiological survey, clinical manifestations, laboratory examinations, imaging findings and etiological tests. The clinical symptoms were gradually relieved and lung lesions became absorbed after tapering and withdrawing immunosuppressants, antiviral therapy of abidol/oseltamivir, antibiotic therapy, hormonal anti-inflammation, oxygen inhalation, nutritional supports and adequate rest.Conclusions:Living-related kidney transplant recipients have specific immunosuppressive states.The long-term effect of covid-19 on recipients should be determined through long-term follow-ups.
